Stephens Has Lowered Expectations for Ardent Health (NYSE:ARDT) Stock Price

Ardent Health (NYSE:ARDT) had its price target dropped by investment analysts at Stephens from $21.00 to $17.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Stephens’ price target suggests a potential upside of 89.44% from the stock’s current price.

Several other equities research analysts have also commented on ARDT. The Goldman Sachs Group initiated coverage on Ardent Health in a research note on Tuesday, October 14th. They set a “neutral” rating and a $19.00 price target on the stock. Wall Street Zen raised Ardent Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 9th. Bank of America cut their price target on Ardent Health from $12.00 to $10.00 and set an “underperform” rating for the company in a research note on Thursday. Weiss Ratings upgraded shares of Ardent Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Finally, KeyCorp dropped their target price on shares of Ardent Health from $24.00 to $20.00 and set an “overweight” rating for the company in a report on Thursday, August 7th. Seven investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $15.91.

Ardent Health Price Performance

Shares of NYSE:ARDT traded down $0.33 on Friday, reaching $8.97. 621,454 shares of the company were exchanged, compared to its average volume of 408,432. The company has a 50-day moving average of $13.88 and a 200-day moving average of $13.36. The company has a current ratio of 2.13, a quick ratio of 2.00 and a debt-to-equity ratio of 0.66. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of 6.19, a price-to-earnings-growth ratio of 6.21 and a beta of 0.44. Ardent Health has a 1-year low of $8.90 and a 1-year high of $17.91.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings data on Wednesday, November 12th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.42 by $0.10. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.55 billion. Ardent Health had a net margin of 3.24% and a return on equity of 19.19%. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. Equities analysts forecast that Ardent Health will post 1.23 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Ardent Health

Hedge funds have recently modified their holdings of the company. Bank of New York Mellon Corp grew its holdings in shares of Ardent Health by 91.2% during the first quarter. Bank of New York Mellon Corp now owns 48,988 shares of the company’s stock worth $674,000 after buying an additional 23,373 shares in the last quarter. Morse Asset Management Inc acquired a new stake in Ardent Health during the first quarter worth approximately $36,000. Y Intercept Hong Kong Ltd purchased a new stake in Ardent Health in the 1st quarter worth approximately $142,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Ardent Health in the 1st quarter worth approximately $422,000. Finally, Vanguard Group Inc. raised its holdings in Ardent Health by 368.9% in the 1st quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock valued at $18,296,000 after acquiring an additional 1,046,845 shares during the last quarter.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.